Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 24, Issue 4, 2011, Pages 225-232

  Delrue, Louke J ^a   Casneuf, Veerle ^a   Van Damme, Nancy ^a   Blanckaert, Peter ^a   Peeters, Marc ^a   Ceelen, Wim P ^a   Duyck, Philippe C O ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

DCE MRI; Gd DOTA; MRI contrast; P792; P846

Indexed keywords

CONTRAST AGENT P792; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOTERIC ACID; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND; P846 COMPOUND;

ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; IMAGE ENHANCEMENT; MALE; METHODOLOGY; MOLECULAR WEIGHT; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; TUMOR CELL LINE; VASCULARIZATION; XENOGRAFT;

ANIMALS; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CONTRAST MEDIA; HETEROCYCLIC COMPOUNDS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MICE; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 80052475863     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-011-0256-9     Document Type: Article

References (33)

1. A Jemal R Siegel J Xu E Ward 2010 Cancer statistics, 2010 CA Cancer J Clin 60 277 300 20610543 10.3322/caac.20073
2. J Folkman 1992 The role of angiogenesis in tumor growth Semin Cancer Biol 3 65 71 1378311 1:STN:280:DyaK38zivFOgtA%3D%3D
3. DM McDonald PL Choyke 2003 Imaging of angiogenesis: from microscope to clinic Nat Med 9 713 725 12778170 10.1038/nm0603-713 1:CAS:528: DC%2BD3sXktFOnurs%3D (Pubitemid 36749220)
4. N Weidner J Folkman F Pozza P Bevilacqua EN Allred DH Moore S Meli G Gasparini 1992 Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma J Natl Cancer Inst 84 1875 1887 1281237 10.1093/jnci/84.24.1875 1:STN:280:DyaK3s%2FpsFWhtA%3D%3D (Pubitemid 23004615)
5. H Daldrup DM Shames M Wendland Y Okuhata TM Link W Rosenau Y Lu RC Brasch 1998 Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media AJR Am J Roentgenol 171 941 949 9762973 1:STN:280:DyaK1cvjtl2gtQ%3D%3D (Pubitemid 28449949)
6. HC Schwickert M Stiskal TP Roberts CF van Dijke J Mann A Muhler DM Shames F Demsar A Disston RC Brasch 1996 Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy Radiology 198 893 898 8628889 1:STN:280:DyaK287psVWjug%3D%3D (Pubitemid 26066316)
7. AR Padhani 2002 Functional MRI for anticancer therapy assessment Eur J Cancer 38 2116 2127 12387837 10.1016/S0959-8049(02)00388-X 1:STN:280: DC%2BD38njtValtg%3D%3D (Pubitemid 35223249)
8. HF Dvorak JA Nagy JT Dvorak AM Dvorak 1988 Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules Am J Pathol 133 95 109 2459969 1:STN:280: DyaL1M%2FitlCksQ%3D%3D
9. QG de Lussanet S Langereis RG Beets-Tan MH van Genderen AW Griffioen JM van Engelshoven WH Backes 2005 Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice Radiology 235 65 72 15731376 10.1148/radiol.2351040411 (Pubitemid 40432238)
10. X Fan M Medved S Foxley JN River M Zamora GS Karczmar C Corot P Robert P Bourrinet 2006 Multi-slice DCE-MRI data using P760 distinguishes between metastatic and non-metastatic rodent prostate tumors Magn Reson Mater Phy 19 15 21 10.1007/s10334-005-0022-y 1:CAS:528:DC%2BD28XksFKhtb8%3D
11. K Turetschek E Floyd T Helbich TP Roberts DM Shames MF Wendland WO Carter RC Brasch 2001 MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology J Magn Reson Imaging 14 237 242 11536400 10.1002/jmri.1179 1:STN:280:DC%2BD3MvptFygsg%3D%3D (Pubitemid 32801057)
12. KG Brurberg IC Benjaminsen LM Dorum EK Rofstad 2007 Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI Magn Reson Med 58 473 481 17763357 10.1002/mrm.21367 (Pubitemid 350154957)
13. W Ceelen T Boterberg P Smeets N Van Damme P Demetter O Zwaenepoel L Cesteleyn P Houtmeyers M Peeters P Pattyn 2007 Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels Br J Cancer 96 692 700 17299396 10.1038/sj.bjc.6603568 1:CAS:528: DC%2BD2sXisVGisr8%3D (Pubitemid 46376614)
14. W Ceelen P Smeets W Backes N Van Damme T Boterberg P Demetter I Bouckenooghe M De Visschere M Peeters P Pattyn 2006 Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model Int J Radiat Oncol 64 1188 1196 10.1016/j.ijrobp.2005.10.026
15. RC Brasch KCP Li JE Husband MT Keogan M Neeman AR Padhani D Shames K Turetschek 2000 In vivo monitoring of tumor angiogenesis with MR imaging Acad Radiol 7 812 823 11048879 10.1016/S1076-6332(00)80630-3 1:STN:280: DC%2BD3crgtFCntQ%3D%3D
16. JS Taylor PS Tofts R Port JL Evelhoch M Knopp WE Reddick VM Runge N Mayr 1999 MR imaging of tumor microcirculation: promise for the new millennium J Magn Reson Imaging 10 903 907 10581502 10.1002/(SICI)1522-2586(199912)10:6<903:: AID-JMRI1>3.0.CO;2-A 1:STN:280:DC%2BD3c%2FltVemsw%3D%3D
17. WT Yuh 1999 An exciting and challenging role for the advanced contrast MR imaging J Magn Reson Imaging 10 221 222 10508280 10.1002/(SICI)1522- 2586(199909)10:3<221::AID-JMRI1>3.0.CO;2-X 1:STN:280:DyaK1Mvjsl2jtg%3D%3D (Pubitemid 29463103)
18. EY Chang X Li M Jerosch-Herold RA Priest CK Enestvedt J Xu CS Springer Jr BA Jobe 2008 The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging J Gastrointest Surg 12 166 175 17768665 10.1007/s11605-007-0253-5
19. QG de Lussanet WH Backes AW Griffioen AR Padhani CI Baeten A van Baardwijk P Lambin GL Beets JM van Engelshoven RG Beets-Tan 2005 Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer Int J Radiat Oncol Biol Phys 63 1309 1315 16125874 10.1016/j.ijrobp.2005.04.052 (Pubitemid 41628023)
20. I Ocak M Bernardo G Metzger T Barrett P Pinto PS Albert PL Choyke 2007 Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters AJR Am J Roentgenol 189 849 17885055 10.2214/AJR.06.1329
21. TE Yankeelov JC Gore 2009 Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples Curr Med Imaging Rev 3 91 107 19829742 10.2174/157340507780619179 (Pubitemid 46773870)
22. TE Yankeelov M Lepage A Chakravarthy EE Broome KJ Niermann MC Kelley I Meszoely IA Mayer CR Herman K McManus RR Price JC Gore 2007 Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results Magn Reson Imaging 25 1 13 17222711 10.1016/j.mri.2006.09.006 (Pubitemid 46048940)
23. VF Casneuf P Demetter T Boterberg L Delrue M Peeters N Van Damme 2009 Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy Oncol Rep 22 105 113 19513511 10.3892/or-00000412 1:CAS:528:DC%2BD1MXoslyms7o%3D
24. M Port C Corot O Rousseaux I Raynal L Devoldere JM Idee A Dencausse S Le Greneur C Simonot D Meyer 2001 P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results Magn Reson Mater Phy 12 121 127 1:CAS:528:DC%2BD3MXkslCntL4%3D (Pubitemid 32510130)
25. A Jacquier M Bucknor L Do P Robert C Corot CB Higgins M Saeed 2008 P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in rats Magn Reson Mater Phy 21 207 218 10.1007/s10334-008-0112-8 1:CAS:528:DC%2BD1cXpt1arsbY%3D
26. PS Tofts 1997 Modeling tracer kinetics in dynamic Gd-DTPA MR imaging JMRI-J Magn Reson Imaging 7 91 101 10.1002/jmri.1880070113 1:STN:280: DyaK2s7ptFKmsA%3D%3D (Pubitemid 28365643)
27. D De Naeyer Y De Deene WP Ceelen P Segers P Verdonck 2011 Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI Magn Reson Mater Phy 24 51 66 10.1007/s10334-010-0235-6
28. X Wu EK Jeong L Emerson J Hoffman DL Parker ZR Lu 2010 Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers Mol Pharm 7 41 48 19958031 10.1021/mp900153f 1:CAS:528:DC%2BD1MXhsFCrsb7N
29. RC Brasch 1992 New directions in the development of MR imaging contrast media Radiology 183 1 11 1549653 1:CAS:528:DyaK38XitlSktbk%3D
30. CF van Dijke RC Brasch TP Roberts N Weidner A Mathur DM Shames JS Mann F Demsar P Lang HC Schwickert 1996 Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density Radiology 198 813 818 8628876 (Pubitemid 26066303)
31. X Fan M Medved JN River M Zamora C Corot P Robert P Bourrinet M Lipton RM Culp GS Karczmar 2004 New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors Magn Reson Med 51 487 494 15004789 10.1002/mrm.10737 1:CAS:528: DC%2BD2cXivVemsb4%3D (Pubitemid 38298661)
32. PS Tofts G Brix DL Buckley JL Evelhoch E Henderson MV Knopp HB Larsson TY Lee NA Mayr GJ Parker RE Port J Taylor RM Weisskoff 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 223 232 10508281 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S 1:STN:280:DyaK1Mvjsl2jtw%3D%3D (Pubitemid 29463104)
33. PL Choyke AJ Dwyer MV Knopp 2003 Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging J Magn Reson Imaging 17 509 520 12720260 10.1002/jmri.10304 (Pubitemid 36528666)